智慧门急诊药房产品
Search documents
艾隆科技11月21日获融资买入743.57万元,融资余额5779.32万元
Xin Lang Cai Jing· 2025-11-24 01:27
Core Viewpoint - On November 21, Ailong Technology experienced a decline of 4.95% with a trading volume of 48.73 million yuan, indicating a potential market reaction to recent financial performance and investor sentiment [1] Financing Summary - On the same day, Ailong Technology had a financing purchase amount of 7.44 million yuan and a financing repayment of 2.52 million yuan, resulting in a net financing purchase of 4.91 million yuan [1] - As of November 21, the total financing and securities lending balance for Ailong Technology was 57.79 million yuan, which accounts for 3.51% of its market capitalization, indicating a low financing balance compared to the 20th percentile over the past year [1] - There were no shares repaid or sold in the securities lending market on November 21, with a total securities lending balance of 0.00 yuan, suggesting a high level of inactivity in this area compared to the 90th percentile over the past year [1] Company Overview - Ailong Technology, established on January 20, 2006, and listed on March 29, 2021, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2] - The company's revenue composition includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [2] - As of September 30, the number of shareholders was 5,144, a decrease of 4.99%, while the average circulating shares per person increased by 5.25% to 15,007 shares [2] Financial Performance - For the period from January to September 2025, Ailong Technology reported a revenue of 280 million yuan, reflecting a year-on-year growth of 25.12%, while the net profit attributable to the parent company was -0.96 million yuan, showing a significant year-on-year improvement of 96.56% [2] Dividend Information - Since its A-share listing, Ailong Technology has distributed a total of 111 million yuan in dividends, with 49.05 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder of Ailong Technology was the Dacheng CSI 360 Internet + Index A (002236), holding 741,700 shares, which is a decrease of 86,500 shares compared to the previous period [3]
艾隆科技股价跌5.04%,大成基金旗下1只基金位居十大流通股东,持有74.17万股浮亏损失83.82万元
Xin Lang Cai Jing· 2025-11-21 06:59
Group 1 - The core point of the news is that Ailong Technology's stock price has dropped by 5.04%, currently trading at 21.31 CNY per share, with a total market capitalization of 1.645 billion CNY [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [1] - The company's main revenue sources include smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among Ailong Technology's top circulating shareholders, Dacheng Fund's index fund has reduced its holdings by 86,500 shares, now holding 741,700 shares, which is 0.96% of the circulating shares [2] - The Dacheng Zhongzheng 360 Internet + Index A fund has achieved a year-to-date return of 38.22% and a one-year return of 39.52%, ranking 871 out of 4208 and 577 out of 3972 respectively [2]
艾隆科技股价跌5.14%,大成基金旗下1只基金位居十大流通股东,持有82.83万股浮亏损失90.28万元
Xin Lang Cai Jing· 2025-09-23 02:53
Group 1 - The core point of the news is that Ailong Technology's stock price dropped by 5.14% to 20.13 CNY per share, with a total market capitalization of 1.554 billion CNY as of the report date [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [1] - The company's revenue composition includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among the top circulating shareholders of Ailong Technology, the Dachen Zhongzheng 360 Internet + Index A fund holds 828,300 shares, accounting for 1.07% of circulating shares, with an estimated floating loss of approximately 902,800 CNY [2] - The Dachen Zhongzheng 360 Internet + Index A fund, established on February 3, 2016, has a current scale of 698 million CNY and has achieved a year-to-date return of 34.45% [2] - The fund manager, Xia Gao, has a tenure of nearly 11 years, with the best fund return during this period being 215.74% [3]
艾隆科技股价跌5.05%,大成基金旗下1只基金位居十大流通股东,持有82.83万股浮亏损失90.28万元
Xin Lang Cai Jing· 2025-08-28 06:21
Group 1 - The core viewpoint of the news is that Ailong Technology's stock has experienced a decline of 5.05%, with a current price of 20.50 yuan per share and a total market capitalization of 1.583 billion yuan [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [1] - The company's main revenue sources include smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among Ailong Technology's top circulating shareholders, Dacheng Fund's index fund has entered the top ten, holding 828,300 shares, which is 1.07% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A fund has achieved a year-to-date return of 34.52% and a one-year return of 94.57% [2] - The fund manager, Xia Gao, has a tenure of 10 years and has managed a total fund size of 2.26 billion yuan, with the best return during his tenure being 217.27% [3]
艾隆科技8月26日获融资买入486.49万元,融资余额6860.95万元
Xin Lang Cai Jing· 2025-08-27 02:13
Group 1 - The core business of Ailong Technology focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [2] - As of August 8, 2025, the number of shareholders in Ailong Technology increased by 3.45% to 4,711, while the average circulating shares per person decreased by 3.33% to 16,387 shares [2] - For the first half of 2025, Ailong Technology reported a revenue of 131 million yuan, a year-on-year decrease of 8.11%, and a net profit attributable to shareholders of -8.39 million yuan, an increase of 55.47% year-on-year [2] Group 2 - Ailong Technology has distributed a total of 111 million yuan in dividends since its A-share listing, with 49.05 million yuan distributed over the past three years [3] - As of June 30, 2025, the sixth largest circulating shareholder of Ailong Technology is Dazheng Zhongzheng 360 Internet+ Index A, holding 828,300 shares as a new shareholder [3] Group 3 - On August 26, Ailong Technology's stock price increased by 0.40%, with a trading volume of 41.91 million yuan [1] - The financing buy-in amount for Ailong Technology on August 26 was 4.86 million yuan, with a net financing buy-in of 643,800 yuan, while the total financing and securities balance reached 68.61 million yuan, accounting for 3.92% of the circulating market value [1] - The securities lending data for Ailong Technology on August 26 showed no shares were lent or repaid, indicating a high level of securities lending balance at 0.00 shares, which is above the 90th percentile over the past year [1]